Zobrazeno 1 - 10
of 363
pro vyhledávání: '"Stephen J. Greene"'
Autor:
Pascal R. D. Clephas, Jishnu Malgie, Jeroen Schaap, Stefan Koudstaal, Mireille Emans, Gerard C. M. Linssen, Grytsje A. deBoer, Loek vanHeerebeek, C. Jan Willem Borleffs, Olivier C. Manintveld, Vanessa vanEmpel, Sandra vanWijk, Mieke van denHeuvel, Carlos daFonseca, Kevin Damman, Jan vanRamshorst, Roland vanKimmenade, Arjen R. T. van deVen, René A. Tio, Dennis vanVeghel, Folkert W. Asselbergs, Rudolf A. deBoer, Peter van derMeer, Stephen J. Greene, Hans‐Peter Brunner‐La Rocca, Jasper J. Brugts
Publikováno v:
ESC Heart Failure, Vol 11, Iss 1, Pp 550-559 (2024)
Abstract Aims Current heart failure (HF) guidelines recommend to prescribe four drug classes in patients with HF with reduced ejection fraction (HFrEF). A clear challenge exists to adequately implement guideline‐directed medical therapy (GDMT) rega
Externí odkaz:
https://doaj.org/article/76fc22140ff146f4acc31d2d5d84e800
Autor:
Hanna K. Gaggin, Stephen J. Greene, Mo Zhou, Dominik Lautsch, Lori D. Bash, Laurence Djatche, Yan Song, James Signorovitch, Andra S. Stevenson, Robert O. Blaustein, Javed Butler
Publikováno v:
International Journal of Cardiology. Cardiovascular Risk and Prevention, Vol 21, Iss , Pp 200278- (2024)
Background: Based on available data from randomized clinical trials, patients with heart failure with reduced ejection fraction (HFrEF) and worsening HF events (WHFE) have substantial disease burden and poor outcomes. WHFE clinical outcome data in no
Externí odkaz:
https://doaj.org/article/d7dad2a515474427b5c9f5664625db9e
Autor:
Abdul Mannan Khan Minhas, Jakrin Kewcharoen, Michael E. Hall, Haider J. Warraich, Stephen J. Greene, Michael D. Shapiro, Erin D. Michos, Andrew J. Sauer, Dmitry Abramov
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 2 (2024)
Background There are limited data on substance use (SU) and cardiovascular disease (CVD)–related mortality trends in the United States. We aimed to evaluate SU+CVD–related deaths in the United States using the Centers for Disease Control and Prev
Externí odkaz:
https://doaj.org/article/b197334e08c940928ea6042ffe2ab016
Autor:
Tiew‐Hwa Katherine Teng, Wan Ting Tay, Wouter Ouwerkerk, Jasper Tromp, A. Mark Richards, Greg Gamble, Stephen J. Greene, Kai‐Hang Yiu, Katrina Poppe, Lieng Hsi Ling, Mayanna Lund, David Sim, Gerard Devlin, Seet Yoong Loh, Richard Troughton, Qing‐wen Ren, Fazlur Jaufeerally, Shao Guang Sheldon Lee, Ru San Tan, Dinna Kar Nee Soon, Gerald Leong, Hean Yee Ong, Daniel P.S. Yeo, Carolyn S.P. Lam, Rob N. Doughty
Publikováno v:
ESC Heart Failure, Vol 10, Iss 2, Pp 1280-1293 (2023)
Abstract Aims We investigated titration patterns of angiotensin‐converting enzyme inhibitors (ACEis)/angiotensin receptor blockers (ARBs) and beta‐blockers, quality of life (QoL) over 6 months, and associated 1 year outcome [all‐cause mortality
Externí odkaz:
https://doaj.org/article/e5c66e06824e45f2ae879bc7a624007f
Autor:
Yuhui Zhang, Chuanyu Gao, Stephen J. Greene, Barry H. Greenberg, Javed Butler, Jing Yu, Zhaofen Zheng, Genshan Ma, Lian Wang, Ping Yang, Xiaoping Ji, Dingli Xu, Jiang Wang, Yao Zhang, Ying Liu, Yan Zhao, Hong Qi, Mei Zhai, Jiayu Feng, Yan Huang, Qiong Zhou, Jian Zhang
Publikováno v:
ESC Heart Failure, Vol 10, Iss 1, Pp 342-352 (2023)
Abstract Aims Heart failure (HF) remains a major public health problem with increasing prevalence in China. This study evaluated the clinical performance and quality measures for HF management to identify gaps in the standardization of care for patie
Externí odkaz:
https://doaj.org/article/8ff2d9b28e5143ec9e21c43142273641
Autor:
Josephine Harrington, Jie‐Lena Sun, Gregg C. Fonarow, Stephen B. Heitner, Punag H. Divanji, Gary Binder, Larry A. Allen, Brooke Alhanti, Clyde W. Yancy, Nancy M. Albert, Adam D. DeVore, G. Michael Felker, Stephen J. Greene
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 10 (2023)
Background Many patients with heart failure (HF) have severely reduced ejection fraction but do not meet threshold for consideration of advanced therapies (ie, stage D HF). The clinical profile and health care costs associated with these patients in
Externí odkaz:
https://doaj.org/article/1562516935a04e21a697a6a639dfaab1
Autor:
Muhammad Shariq Usman, Muhammad Shahzeb Khan, Gregg C. Fonarow, Stephen J. Greene, Tim Friede, Muthiah Vaduganathan, Gerasimos Filippatos, Andrew J. Stewart Coats, Stefan D. Anker, Javed Butler
Publikováno v:
ESC Heart Failure, Vol 9, Iss 2, Pp 885-893 (2022)
Abstract Aims Recent trials have evaluated sodium–glucose co‐transporter 2 inhibitors in patients with heart failure (HF). We sought to assess the robustness of findings from these trials using the fragility index (FI). Methods and results Fragil
Externí odkaz:
https://doaj.org/article/0f8e31a4617d400987e8af5bf3e7a28a
Autor:
Husam M. Salah, Abdul Mannan Khan Minhas, Muhammad Shahzeb Khan, Safi U. Khan, Andrew P. Ambrosy, Vanessa Blumer, Muthiah Vaduganathan, Stephen J. Greene, Ambarish Pandey, Marat Fudim
Publikováno v:
ESC Heart Failure, Vol 9, Iss 2, Pp 947-952 (2022)
Abstract Aims Hospitalization for heart failure (HF) constitutes a major healthcare and economic burden. Trends and characteristics of hospitalizations for HF for the recent years are not clear. We sought to determine the trends and characteristics o
Externí odkaz:
https://doaj.org/article/828a1178d9dc4cd1a7ba51240a3afe53
Autor:
Husam M. Salah, Subhi J. Al’Aref, Muhammad Shahzeb Khan, Malek Al-Hawwas, Srikanth Vallurupalli, Jawahar L. Mehta, J. Paul Mounsey, Stephen J. Greene, Darren K. McGuire, Renato D. Lopes, Marat Fudim
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-8 (2022)
Abstract Background There is uncertainty and limited data regarding initiation of sodium-glucose cotransporter 2 (SGLT2) inhibitors among patients hospitalized with acute heart failure (AHF). This systematic review and meta-analysis aim to establish
Externí odkaz:
https://doaj.org/article/f4c525969e244f379e199d34138ac9d7
Autor:
Amir Razaghizad, Emily Oulousian, Varinder Kaur Randhawa, João Pedro Ferreira, James M. Brophy, Stephen J. Greene, Julian Guida, G. Michael Felker, Marat Fudim, Michael Tsoukas, Tricia M. Peters, Thomas A. Mavrakanas, Nadia Giannetti, Justin Ezekowitz, Abhinav Sharma
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 10 (2022)
Background Clinical prediction models have been developed for hospitalization for heart failure in type 2 diabetes. However, a systematic evaluation of these models’ performance, applicability, and clinical impact is absent. Methods and Results We
Externí odkaz:
https://doaj.org/article/7f05e3fbff4e4caf944a6d75a396c00b